Search

everythinglearnresearchcommunity

for

Search:↓

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Lichen planus may be associated with a higher risk of metabolic syndrome.

True facial beauty is natural, but cosmetic procedures can enhance it temporarily.

Platelet-Rich Plasma may improve skin health and reduce wrinkles, but more research is needed for standard treatment guidelines.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

New therapies are being developed that target integrin pathways to treat various diseases.